Outer membrane vesicles of the VA‐MENGOC‐BC® vaccine against serogroup B <b><i>of Neisseria meningitidis</i></b>: Analysis of protein components by two‐dimensional gel electrophoresis and mass spectrometry
Liliam Uli(Finlay Institute), Rolando Pajón Feyt(Centro de Ingeniería Genética y Biotecnología), Lázaro Betancourt(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Franklin Sotolongo(Finlay Institute), Lila Castellanos‐Serra, Francisco Domı́nguez(Pontificia Universidad Católica de Chile), Ramón Barberá(Finlay Institute)
Cited by 60
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139